Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label …
Background Pleural mesothelioma usually presents at an advanced, incurable stage.
Chemotherapy with platinum–pemetrexed is a standard treatment. We hypothesised that the …
Chemotherapy with platinum–pemetrexed is a standard treatment. We hypothesised that the …
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label …
Q Chu, F Perrone, L Greillier, W Tu… - Lancet (London …, 2023 - europepmc.org
Background Pleural mesothelioma usually presents at an advanced, incurable stage.
Chemotherapy with platinum-pemetrexed is a standard treatment. We hypothesised that the …
Chemotherapy with platinum-pemetrexed is a standard treatment. We hypothesised that the …
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label …
Q Chu, F Perrone, L Greillier, W Tu, MC Piccirillo… - The Lancet, 2023 - hal.science
Atezolizumab is an anti‐PDL1 approved for treating lung cancer. A threshold of 6 μg/mL in
plasma has been associated with target engagement. The extent to which patients could be …
plasma has been associated with target engagement. The extent to which patients could be …
Journal Club
Biuletyn Polskiego Towarzystwa Onkologicznego …, 2024 - journals.viamedica.pl
Metody. W otwartym międzynarodowym badaniu klinicznym III fazy, prowadzonym w 51
szpitalach w Kanadzie, Włoszech i Francji, wcześniej nieleczonych chorych na …
szpitalach w Kanadzie, Włoszech i Francji, wcześniej nieleczonych chorych na …
[PDF][PDF] Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label …
Q Chu, F Perrone, L Greillier, W Tu, MC Piccirillo… - 2023 - ifct.fr
Background Pleural mesothelioma usually presents at an advanced, incurable stage.
Chemotherapy with platinum–pemetrexed is a standard treatment. We hypothesised that the …
Chemotherapy with platinum–pemetrexed is a standard treatment. We hypothesised that the …
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label …
Q Chu, F Perrone, L Greillier, W Tu… - Lancet (London …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Pleural mesothelioma usually presents at an advanced, incurable stage.
Chemotherapy with platinum-pemetrexed is a standard treatment. We hypothesised that the …
Chemotherapy with platinum-pemetrexed is a standard treatment. We hypothesised that the …
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label …
Q Chu, F Perrone, L Greillier, W Tu, MC Piccirillo… - The Lancet, 2023 - Elsevier
Background Pleural mesothelioma usually presents at an advanced, incurable stage.
Chemotherapy with platinum–pemetrexed is a standard treatment. We hypothesised that the …
Chemotherapy with platinum–pemetrexed is a standard treatment. We hypothesised that the …
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label …
Q Chu, F Perrone, L Greillier, W Tu, MC Piccirillo… - The Lancet, 2023 - thelancet.com
Background Pleural mesothelioma usually presents at an advanced, incurable stage.
Chemotherapy with platinum–pemetrexed is a standard treatment. We hypothesised that the …
Chemotherapy with platinum–pemetrexed is a standard treatment. We hypothesised that the …